2018 Government Medical Primary Care 
Physician's Weekly
JUNE 17, 2025
Tianeptine is sold in a number of countries as a government-approved treatment for depression. But the FDA has never approved it for any medical condition in the U.S. Calello explained that it falls under a gray area of consumer supplements or products that are not regulated or tested the same way a medication would be.
Common Sense Family Doctor
MARCH 23, 2025
This post first appeared on March 6, 2018, during the first Trump administration's failed attempt to eliminate the Agency for Healthcare Research and Quality (AHRQ). Now the Department of Government Efficiency is trying again, threatening 90% staff reductions that would decimate the agency. Update: the NGC ceased operating in 2018.]
Expert insights. Personalized for you.
52 
Let's personalize your content